Published in Microb Pathog on February 01, 2000
The Salmonella enterica serotype typhimurium effector proteins SipA, SopA, SopB, SopD, and SopE2 act in concert to induce diarrhea in calves. Infect Immun (2002) 2.88
Molecular pathogenesis of Salmonella enterica serotype typhimurium-induced diarrhea. Infect Immun (2003) 2.25
The Dot/Icm type IV secretion system of Legionella pneumophila is essential for the induction of apoptosis in human macrophages. Infect Immun (2002) 1.41
Molecular insights into farm animal and zoonotic Salmonella infections. Philos Trans R Soc Lond B Biol Sci (2009) 1.31
Type III secretion: a bacterial device for close combat with cells of their eukaryotic host. Philos Trans R Soc Lond B Biol Sci (2000) 1.30
Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect Immun (2007) 1.29
Selective inhibition of type III secretion activated signaling by the Salmonella effector AvrA. PLoS Pathog (2009) 1.29
Salmonella type III effector AvrA stabilizes cell tight junctions to inhibit inflammation in intestinal epithelial cells. PLoS One (2008) 1.28
Repertoire, unified nomenclature and evolution of the Type III effector gene set in the Ralstonia solanacearum species complex. BMC Genomics (2013) 1.23
Cycle inhibiting factors (CIFs) are a growing family of functional cyclomodulins present in invertebrate and mammal bacterial pathogens. PLoS One (2009) 1.08
Salmonella enterica serovar typhimurium-dependent regulation of inducible nitric oxide synthase expression in macrophages by invasins SipB, SipC, and SipD and effector SopE2. Infect Immun (2000) 1.07
Variation between pathogenic serovars within Salmonella pathogenicity islands. J Bacteriol (2003) 1.00
Morphologic and cytokine profile characterization of Salmonella enterica serovar typhimurium infection in calves with bovine leukocyte adhesion deficiency. Vet Pathol (2009) 0.87
Identification of a host 14-3-3 Protein that Interacts with Xanthomonas effector AvrRxv. Physiol Mol Plant Pathol (2008) 0.81
Bacterial protein AvrA stabilizes intestinal epithelial tight junctions via blockage of the C-Jun N-terminal kinase pathway. Tissue Barriers (2015) 0.80
Lack of effect of the Salmonella deubiquitinase SseL on the NF-κB pathway. PLoS One (2013) 0.78
Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med (1996) 4.09
A secreted effector protein of Salmonella dublin is translocated into eukaryotic cells and mediates inflammation and fluid secretion in infected ileal mucosa. Mol Microbiol (1997) 3.41
SopE, a secreted protein of Salmonella dublin, is translocated into the target eukaryotic cell via a sip-dependent mechanism and promotes bacterial entry. Mol Microbiol (1996) 3.19
SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphate phosphatase. Proc Natl Acad Sci U S A (1998) 2.73
The Yersinia YpkA Ser/Thr kinase is translocated and subsequently targeted to the inner surface of the HeLa cell plasma membrane. Mol Microbiol (1996) 2.65
Molecular basis of Salmonella-induced enteritis. Mol Microbiol (2000) 2.64
Salmonella SirA is a global regulator of genes mediating enteropathogenesis. Mol Microbiol (1999) 2.33
Mutation of invH, but not stn, reduces Salmonella-induced enteritis in cattle. Infect Immun (1998) 2.29
The costs of exacerbations in chronic obstructive pulmonary disease (COPD). Respir Med (2002) 2.29
Identification of a pathogenicity island required for Salmonella enteropathogenicity. Mol Microbiol (1998) 2.23
Bacterial copper- and zinc-cofactored superoxide dismutase contributes to the pathogenesis of systemic salmonellosis. Mol Microbiol (1997) 2.23
The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Mol Microbiol (1998) 2.11
Secreted effector proteins of Salmonella dublin act in concert to induce enteritis. Infect Immun (1998) 1.95
Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J Clin Invest (2001) 1.95
Characterization of intestinal invasion by Salmonella typhimurium and Salmonella dublin and effect of a mutation in the invH gene. Infect Immun (1995) 1.75
Identification of SopE2, a Salmonella secreted protein which is highly homologous to SopE and involved in bacterial invasion of epithelial cells. J Bacteriol (2000) 1.74
Current perspectives in salmonellosis. Br Vet J (1995) 1.72
Differential cytokine expression in avian cells in response to invasion by Salmonella typhimurium, Salmonella enteritidis and Salmonella gallinarum. Microbiology (2000) 1.65
Importance of creatinine analyses of urine when screening for abused drugs. Clin Chem (1991) 1.60
Hereditary papillary renal cell carcinoma: clinical studies in 10 families. J Urol (1995) 1.53
The mouse IgH 3'-enhancer. Eur J Immunol (1991) 1.50
Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease. Ann N Y Acad Sci (1998) 1.46
A new gene of the f1 operon of Y. pestis involved in the capsule biogenesis. FEBS Lett (1992) 1.44
Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol (1994) 1.44
Salmonella pathogenicity island 2 influences both systemic salmonellosis and Salmonella-induced enteritis in calves. Infect Immun (2001) 1.43
The early dynamic response of the calf ileal epithelium to Salmonella typhimurium. Vet Pathol (1997) 1.41
The secreted effector protein of Salmonella dublin, SopA, is translocated into eukaryotic cells and influences the induction of enteritis. Cell Microbiol (2000) 1.40
The final phase in acute myeloid leukaemia (AML): a study of cause of death, place of death and type of care during the last week of life. Leuk Res (2001) 1.40
Crucial influence of solvent and chirality-the formation of helices and three-dimensional nets by hydrogen-bonded biimidazolate complexes. Chemistry (2001) 1.39
Dependence on sedative-hypnotics: neuropsychological impairment, field dependence and clinical course in a 5-year follow-up study. Br J Addict (1989) 1.38
Micro anion exchange chromatography of carbohydrate-deficient transferrin in serum in relation to alcohol consumption (Swedish Patent 8400587-5). Alcohol Clin Exp Res (1986) 1.37
Flagellar phase variation of Salmonella enterica serovar Typhimurium contributes to virulence in the murine typhoid infection model but does not influence Salmonella-induced enteropathogenesis. Infect Immun (2001) 1.37
The nature and role of mucosal damage in relation to Salmonella typhimurium-induced fluid secretion in the rabbit ileum. J Med Microbiol (1986) 1.37
Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J Pediatr Gastroenterol Nutr (2001) 1.35
Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma. Br Med J (Clin Res Ed) (1984) 1.31
Studies on early association of Salmonella typhimurium with intestinal mucosa in vivo and in vitro: relationship to virulence. J Med Microbiol (1989) 1.31
Salmonella typhimurium mutants that downregulate phagocyte nitric oxide production. Cell Microbiol (2000) 1.28
Relationships between human-animal interactions and productivity of commercial dairy cows. J Anim Sci (2000) 1.27
A randomized study of secondary prevention of early stage problem drinkers in primary health care. Br J Addict (1989) 1.25
Kinetics, tissue specificity and pathological changes in murine rotavirus infection of mice. J Gen Virol (1986) 1.25
Salmonella enterica serovar-host specificity does not correlate with the magnitude of intestinal invasion in sheep. Infect Immun (2001) 1.25
Nucleotide sequence and genomic organization of Aedes densonucleosis virus. Virology (1991) 1.23
Bacteriology of upper urinary tract stones. J Urol (1990) 1.21
An electron microscopic investigation of time-related changes in the intestine of neonatal mice infected with murine rotavirus. J Pediatr Gastroenterol Nutr (1988) 1.21
Predominant role of NF-kappa B p65 in the pathogenesis of chronic intestinal inflammation. Immunobiology (1997) 1.20
Salmonella enterica serovars Typhimurium and Dublin can lyse macrophages by a mechanism distinct from apoptosis. Infect Immun (2000) 1.19
Identification of Ets-like lymphoid specific elements within the immunoglobulin heavy chain 3' enhancer. Nucleic Acids Res (1992) 1.17
A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence. Alcohol Clin Exp Res (2003) 1.17
Interaction of Salmonella choleraesuis, Salmonella dublin and Salmonella typhimurium with porcine and bovine terminal ileum in vivo. Microbiology (1999) 1.16
Caf1R gene and its role in the regulation of capsule formation of Y. pestis. FEBS Lett (1992) 1.12
Clinical significance of abnormal heterogeneity of transferrin in relation to alcohol consumption. Acta Med Scand (1979) 1.12
Constitutive function of the basic helix-loop-helix/PAS factor Arnt. Regulation of target promoters via the E box motif. J Biol Chem (1995) 1.11
Outpatient-based extracorporeal shock wave lithotripsy using EDAP LT-01. Scand J Urol Nephrol Suppl (1991) 1.09
Common variants in HNF-1 alpha and risk of type 2 diabetes. Diabetologia (2006) 1.09
The effects of cognitive behavioral intervention on the attitude and behavior of stockpersons and the behavior and productivity of commercial dairy cows. J Anim Sci (2002) 1.06
A "trans" perspective on the control of immunoglobulin c gene expression. Immunol Rev (1982) 1.05
Evidence of a reduced sialic acid content in serum transferrin in male alcoholics. Alcohol Clin Exp Res (1981) 1.05
The Salmonella virulence plasmid enhances Salmonella-induced lysis of macrophages and influences inflammatory responses. Infect Immun (1996) 1.05
A mouse model for adenovirus gene delivery. Proc Natl Acad Sci U S A (2001) 1.04
Interaction of Salmonella serotypes with porcine macrophages in vitro does not correlate with virulence. Microbiology (2000) 1.03
IgM receptor-mediated transactivation of the IgH 3' enhancer couples a novel Elf-1-AP-1 protein complex to the developmental control of enhancer function. EMBO J (1995) 1.03
Isotype exclusion and transgene down-regulation in immunoglobulin-lambda transgenic mice. Nature (1989) 1.02
Bacterial regulation of intestinal immune responses. Inflamm Bowel Dis (2000) 1.01
Differential regulation of enteric and systemic salmonellosis by slyA. Infect Immun (1999) 1.01
Vaccination against nicotine alters the distribution of nicotine delivered via cigarette smoke inhalation to rats. Biochem Pharmacol (2011) 1.01
Quantitative estimation of abnormal microheterogeneity of serum transferrin in alcoholics. Pharmacol Biochem Behav (1980) 1.01
Natural history of renal artery aneurysm elucidated by repeated angiography and pathoanatomical studies. Eur Urol (1985) 1.00
Effects of free radical scavengers on renal circulation after ischaemia in the rabbit. Clin Sci (Lond) (1983) 1.00
Salmonellosis: in retrospect and prospect. Ciba Found Symp (1985) 0.99
Mutation of waaN reduces Salmonella enterica serovar Typhimurium-induced enteritis and net secretion of type III secretion system 1-dependent proteins. Infect Immun (2000) 0.99
The bacterial protein YopJ abrogates multiple signal transduction pathways that converge on the transcription factor CREB. Cell Microbiol (2000) 0.97
Repression of the immunoglobulin heavy chain 3' enhancer by helix-loop-helix protein Id3 via a functionally important E47/E12 binding site: implications for developmental control of enhancer function. Eur J Immunol (1995) 0.97
Paediatric drug use with focus on off-label prescriptions in Swedish outpatient care--a nationwide study. Acta Paediatr (2011) 0.97
Intestinal enzyme profiles in normal and rotavirus-infected mice. J Pediatr Gastroenterol Nutr (1988) 0.96
Surgical removal of bone and muscle metastases of renal cancer. Acta Orthop Scand (1984) 0.96
A Lotus japonicus cDNA encoding an alpha subunit of a heterotrimeric G-protein. Plant Physiol (1994) 0.95
B lymphocyte activation upon exclusive recognition of major histocompatibility antigens by T helper cells. Eur J Immunol (1984) 0.95
Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague. Microb Pathog (1999) 0.95
Drug and treatment costs in Parkinson's disease patients in Sweden. Acta Neurol Scand (2011) 0.95
Enterotoxin production by Salmonella typhimurium strains of different virulence. J Med Microbiol (1986) 0.94
Inhibition of activated/memory (CD45RO(+)) T cells by oxidative stress associated with block of NF-kappaB activation. J Immunol (2001) 0.94
Ureaplasma urealyticum and upper urinary tract stones. Br J Urol (1984) 0.94
Early interactions of Salmonella enterica serovar typhimurium with human small intestinal epithelial explants. Gut (2004) 0.94
Abstinence fear in methadone maintenance withdrawal: a possible obstacle for getting off methadone. Subst Use Misuse (1997) 0.94
Angiographically discovered, non-operated renal artery aneurysms. Scand J Urol Nephrol (1984) 0.93
Cutting edge: Ig heavy chain 3' HS1-4 directs correct spatial position-independent expression of a linked transgene to B lineage cells. J Immunol (1999) 0.93
T cell-dependent B cell activation. Immunol Rev (1984) 0.92
The Salmonella dublin virulence plasmid does not modulate early T-cell responses in mice. Infect Immun (1996) 0.92
Partial or total gastrectomy for adenocarcinoma of the cardia. Acta Chir Scand (1969) 0.92
Lipopolysaccharide-dependent transactivation of the temporally regulated immunoglobulin heavy chain 3' enhancer. Eur J Immunol (1994) 0.91